Skip to content

OKUR ONKURE THERAPEUTICS INC

Follow

COM CL A (common), issuer CIK 1637715

1 manager (1 13F filer) reported a position in OKUR shares at 2024-09-30, 3,200 shares in all. 1 filer opened a position and 0 filers sold out during the quarter.

Managers
1
13F filers
1
New
1
Added
0
Reduced
0
Sold out
0
Shares held by filers
3,200

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2024

Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Catalyst Funds Management Pty Ltd3,200$5.44K<0.01%new13F-HRTimeline

Events

  • Coastlands Capital LP and 4 other reporting persons reported 2,700,000 OKUR shares, 6.67% of the class, as of 2026-10-01, in a 13G filed 2026-10-07. 0001104659-26-114447

    Accepted , ingested